Nortriptyline Glenmark Pharmaceuticals Europe (Nortriptyline)

• Nortriptyline is used in several therapeutic areas that involve mood regulation and pain modulation.
• Depression: reduces depressive symptoms and improves mood in adults.
• Neuropathic pain: alleviates pain associated with diabetic neuropathy or post‑herpetic neuralgia.
• Chronic tension‑type headache: decreases frequency and intensity of tension‑type headaches.
• Migraine prophylaxis: lowers the number of migraine attacks when taken regularly.

• Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their synaptic concentrations, and antagonizes muscarinic, histamine H1, and α1‑adrenergic receptors. This combined action enhances neurotransmission in mood‑regulating pathways and reduces neuronal excitability involved in pain transmission.

Nortriptyline may cause a range of adverse reactions, which are commonly grouped by frequency and severity.

Common Side Effects

• Dry mouth: reduced salivation leading to discomfort.
• Constipation: slowed gastrointestinal motility.
• Drowsiness: increased sedation, especially at treatment initiation.
• Weight gain: gradual increase in body weight.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, particularly in patients with pre‑existing heart disease.
• Seizures: heightened risk in susceptible individuals.
• Severe hypotension: sudden drop in blood pressure upon standing.
• Suicidal thoughts: emergence or worsening of suicidal ideation, especially early in therapy.

• When prescribing nortriptyline, clinicians should consider several safety aspects to minimize risk.
• Cardiac assessment: evaluate patients with known heart disease or arrhythmias before initiating therapy.
• Suicidality monitoring: observe for worsening depression or suicidal thoughts, especially early in treatment.
• Drug‑induced seizures: avoid in patients with a seizure history unless benefits outweigh risks.
• Alcohol use: counsel patients to limit alcohol as it may increase sedation and hypotension.
• Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and light.

Nortriptyline can interact with a variety of medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): concurrent use can cause hypertensive crisis or serotonin syndrome.
• Selective serotonin reuptake inhibitors (SSRIs) or other serotonergic agents: risk of serotonin syndrome.
• Thioridazine or other QT‑prolonging drugs: may increase risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

• Antihistamines and other sedatives: may enhance drowsiness and impair cognition.
• Carbamazepine and other enzyme inducers: can reduce nortriptyline plasma levels.
• Warfarin: may increase bleeding risk; monitor INR closely.